Over the nearly eight-year trial, 14 patients out of 33 involved achieved completeremission from their cancer, and tumours in three of the patients shrank by 50% or more.
Most people with multiple sclerosis, particularly in the beginning stages of the disease, experience relapses of symptoms, which are followed by periods of complete or partial remission of symptoms.